Genezen is a technical and quality-focused CDMO dedicated to advancing gene and cell therapies by providing viral vector services and manufacturing solutions. self-described.

Genezen

Genezen | 5,517 followers on LinkedIn. Accelerating the Pace of Cell Therapy CMC and Clinical Development | Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the company&#39;s expansive knowledge and experience in the industry and working with the nation&#39;s leading institutions. For more information, or to learn more about services offered in Genezen&#39;s new cGMP facility, please visit our website: www.genezen.com

Director of Program Management at Genezen

Gina Di Sanzo

Associate Director, Quality Control Analytical/Bioassay / Genezen

Kenya Prince Cohane

Susan D'Costa

EVP, Commercial Operations

Dave Wilhite

🌟 SURVEY RESULTS 🌟 In July 2024, we conducted a survey among top executives at biopharmaceutical companies and payor organizations to uncover how their strategies for negotiating reimbursement are shaping the development and commercialization of cell and gene therapies. Click below to see the results! #cdmo #genetherapy #cellandgenetherapy #viralvectors #pharma #biotech #payor #reimbursement #healthcare

🌟 PANEL ALERT 🌟 Pratima Cherukuri , Chief Scientific Officer for Genezen , will present on a panel entitled The Importance of Diagnostic Development in Cell and Gene Therapy Product Development on Wednesday, November 13th at the Advanced Therapies 2024 meeting in Philadelphia. #viralvectors #CDMO #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech

We're excited to welcome Pam Stetkiewicz and Stuart Auerbach to our Board of Directors! With their extensive expertise in manufacturing and drug development, they will play a pivotal role in advancing Genezen as a best-in-class viral vector CDMO. https://lnkd.in/gx7J8AUd #CDMO #viralvectors #celltherapy #genetherapy #cellandgenetherapy

📣 NEW BLOG 📣 "Due to their therapeutic potential, the production of lentiviral vectors must meet the highest reliability and quality standards to ensure safety and efficacy. Reliable lentiviral vector production services are crucial for advancing gene therapy applications and clinical research." We stand at the forefront of lentiviral vector production, combining quality and precision to provide high-performing viral vectors. Learn more about our lentivirus production services: https://lnkd.in/e55bxur8 #CDMO #viralvectors #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech

🗓️ SCHEDULE A CHAT 📅 Our team will be in Philly in just a couple of weeks for Advanced Therapies USA 2024. We would love to talk with you about current and upcoming projects, whether it's a la carte assistance or concept to commercial. Reach out directly to Pratima Cherukuri , Megan Hardy , and Achyuta Teella or by clicking here: https://lnkd.in/ej5uSuAD #viralvectors #CDMO #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech #

🌟 PRESENTATION ALERT 🌟 Emily Carney , Senior Manager of Site Project Management, will present alongside Nicole Woon from Microsoft at the Society of Women Engineers annual conference in Chicago today. Emily has been very involved in this organization throughout her career- currently serving on the editorial board, contributing articles in its magazine, and participating as a mentor. We are proud of Emily and her service to this organization of 50k members worldwide supporting women in engineering and technology. #togetherwerise #we24 #engineering #womenengineers #viralvectors #cdmo #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech

🕰️ HAPPENING NOW 🕰️ Don't miss your chance to talk with Zuelay E. Rosario, PhD about our viral vector manufacturing capabilities! Message her here on LinkedIn or via our website to set a time: https://lnkd.in/ej5uSuAD #viralvectors #cdmo #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech

🏛️ ROME BOUND 🏛️ Zuelay E. Rosario, PhD will attend the European Society of Gene and Cell Therapy in Rome next week. Set some time to chat with her while you're there! https://lnkd.in/ej5uSuAD #viralvectors #cdmo #celltherapy #genetherapy #cellandgenetherapy #pharma #biotech

🤝 GENEZEN CARES 🤝 Arturo Blanquera, senior manager of automation engineering, and his wife Shannan are currently in North Carolina delivering the thousands of pounds of aid they collected for Hurricane Helene relief. Arturo coordinated this mission of mercy through the local The American Legion . We were honored to serve as a collection point and support recovery efforts. We believe in the whole person here at Genezen. To learn more about our team, click here: https://lnkd.in/emVGYgWR . #viralvectors #CDMO #celltherapy #genetherapy #cellandgenetherapy #biotech #pharma #hurricanerelief #hurricanehelene #northcarolina

🎬 THAT'S A WRAP 🎬 Pratima Cherukuri had a marvelous presentation about our capabilities to round out our presence at Alliance for Regenerative Medicine 's Meeting on the Mesa. Did you miss the presentation or your chance to talk with us? Don't worry! You can reach us right here on our website: https://lnkd.in/ej5uSuAD . Your next chance to catch us in person is coming up in Rome at ESGCT from October 22-25th! #cdmo #viralvectors #celltherapy #genetherapy #cellandgenetherapy #biotech #pharma #CGMesa24

DNSSEC

Amazon

Cloudflare CDN

Cloudflare

Cloudflare Network Error Logging

Amazon Virginia Region

Cloudflare Bot Manager

Hubspot Hosted

Linode

SMTP2GO

Founder & Executive Chairman

Bill Vincent

Chief Scientific Officer

Pratima Cherukuri

Chief Executive Officer

Ray Kaczmarek

Chief Business Officer

Rebecca Lyon

Vice President Operations

Brok Weichbrodt

VP of Business Development and Marketing

Katherine Moynihan

Vice President of Quality and Regulatory

Natasha Rivas

VP of Alliance Management

Associate Director of Upstream Process Development

Hao Yu

Steven J. Favaloro

President & Chief Executive Officer

Michael Wourms

Great Lakes Companies With More Than 50 Employees (Top 10K)

Biotechnology Companies With Fewer Than 1000 Employees (Top 10K)

Manufacturing Companies With Fewer Than 1000 Employees (Top 10K)

Midwestern US Biotechnology Companies

Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

Ampersand Capital Partners

Venture Round - Genezen

Indianapolis

Indiana

United States

North America

Powerful women are gathering their thoughts post-election, and marshaling resources for what comes next

Genezen Welcomes Industry Experts Dr. Pam Stetkiewicz and Stuart Auerbach to Board of Directors

Genezen Appoints Mike Wourms as Chief Operations Officer

Genezen’s Acquisition of Gene Therapy Manufacturing Facility

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

Genezen acquires uniQure's gene therapy operations

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

UniQure sells gene therapy manufacturing site to Genezen, along with production of CSL's Hemgenix

Manufacturing of viral vectors under Good Manufacturing Practice (GMP) conditions, ensuring compliance with regulatory standards for clinical and commercial use.

Production of cells that have been genetically modified using viral vectors for therapeutic applications.

Development of scalable and reproducible processes for the production of viral vectors and transduced cells.

Comprehensive testing services including vector stability, safety, sterility, and Recombinant Competent Lentivirus (RCL) testing.

A licensed proprietary system for stable and scalable high-titer clinical lentivirus production.

news impact assignment basic	general
public peers	general	Nov 16, 2024 1:24 PM	5f46969b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 16, 2024 1:24 PM	4360e321
crunchbase trigger	general	Nov 16, 2024 1:24 PM	34d02cb3
crunchbase profile	general	Nov 16, 2024 1:27 PM	b02ba6a2
li profile	general	Nov 16, 2024 1:24 PM	b02bd220
translate crunchbase fundingrounds	general	Nov 16, 2024 1:47 PM	723e1e6f
peers	general	Nov 16, 2024 1:24 PM	61b013b8
news basic	general	Nov 16, 2024 1:24 PM	0ae445b9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

GENE

COM:GENEZEN

Genezen